Starbucks Climbs 10% After Q4 Earnings: See What VectorVest Recommends You Do Next
Everyone’s favorite coffee giant - Starbucks (SBUX) - is on track for its greatest single-day percentage increase since February 2020 - right before the pandemic restrictions set in. So far, the stock is up 10% in Friday morning trading. How did we get here? Yesterday after market hours, Starbucks quietly released its fiscal fourth-quarter earnings report. And as you [...]
NerdWallet Jumps 35%+ After Q3 Earnings & Analyst Adjustments – is This Your Sign to Buy?
NerdWallet reported an impressive third quarter showing growth in revenue, EPS, and other key metrics. As a result, analysts have moved their price targets for the stock up - and investors have gotten on board as well. Hype after this news has sent the stock up 36% so far this morning. And by the end of this quick discussion, [...]
Airbnb Posts Record-Breaking Profits in Q3 – So Why is it Down Almost 10% Today?
Tuesday morning, Airbnb (ABNB) reported Q3 earnings that exceeded not just analyst expectations - but the company’s best performance to date. It was the biggest and most profitable quarter in company history, and yet, shares are trading down 10% so far today…what’s going on? Before we can look at potential causes for the drop in stock price despite an [...]
Carvana is up 15% After JPMorgan Upgrade – Did They Miss These 3 Red Flags?
Early this morning Carvana surged 15% before leveling off and dipping back down a bit. However, this is the first positive price movement the online vehicle retailer has seen in quite some time. The reason for this quick jump? The stock was upgraded from “underweight” to “neutral” by an analyst at JPMorgan. While most analysts - and investors - [...]
Actinium Pharmaceuticals (ATNM) Jumps 39% After Trial Results – Here’s What Investors Should Do…
Actinium Pharmaceuticals (ATNM) is one of the biggest movers early Monday morning. The stock is up 39% for the day after the firm released news that their latest trial results were more than optimistic. The company specializes in developing targeted therapies for cancer. Their therapies are known as antibody radiation conjugates - a special treatment that leverages the targeting [...]
Nuvalent Gains 50%+ After Positive Trial Results – Is This Reason Enough to Buy?
As of 11 AM EST Friday morning, Nuvalent has gained over 50% on its share price. The stock topped out at around $38/share (a 75% gain) but has started to trend back downwards and currently sits at $33/share. What happened to cause this spike? The company creates precisely targeted cancer treatments designed to overcome the limitations of existing [...]